Loading clinical trials...

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00936065

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

To compare the efficacy of ETN 50mg twice weekly for 12 weeks followed by reduction to a maintenance dose of 25mg twice weekly at week 24 with that of combination of ETN 25 mg Twice Weekly plus Acitre...

Lead sponsor: Pfizer•10 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1/2

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

NCT05344248 · Moderate to Severe Psoriasis

COMPLETEDPhase 3

CLEAR Study: Clinical Experience Acquired With Raptiva Study

NCT00256139 · Moderate to Severe Psoriasis

COMPLETEDPhase 3

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

NCT00442650 · Moderate to Severe Psoriasis

TERMINATED

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

NCT01156532 · Moderate to Severe Psoriasis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment60

Start dateJul 2009

Last updatedApr 9, 2012

Condition

Moderate to Severe Psoriasis

Locations shown

Pfizer Investigational Site

Daejeon, Korea

Pfizer Investigational Site

Gyeonggido, Korea

Pfizer Investigational Site

Seoul, Korea

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Trial snapshot

Condition

Locations shown

For caregivers